ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

SWOG Closes Prostate Cancer Trial With Mitoxantrone

February 23, 2007

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

Emphasis On Early Disease In Clinical Trials, Early Lung Cancer Detection Seen As “Landmark”

September 19, 1975

Rescission Cuts $5-6 Mil. From NCI FY94 Appropriations , Affects Intramural Program

March 11, 1994

Golde To Step Down As Physician-in-Chief At Memorial Sloan-Kettering Next Year.

January 26, 2001

In Brief: Hendrix To Head Children’s Memorial Institute

June 20, 2003